Clinical trials

  • OXYBUTYNIN for Posterior urethral valves
  • Botulinum toxin type A for Post-surgical scar pain
  • TARLATAMAB for Small-cell lung cancer (metastatic/locally advanced) | Poorly differentiated neuroendocrine carcinoma | High-grade medullary thyroid carcinoma (MTC)
  • ALN-4324 for Type 2 diabetes mellitus
  • CENERIMOD for Systemic lupus erythematosus (moderate to severe)
  • ZILTIVEKIMAB for Coronary artery disease
  • EPROSARTAN MESILATE for Type 2 diabetes
  • ATEZOLIZUMAB for Large-cell neuroendocrine carcinoma of the lung
  • Capecitabine for Gastric adenocarcinoma|Gastroesophageal junction adenocarcinoma
  • DURVALUMAB for Stage III non-small cell lung cancer
  • Clinical trial in Rheumatoid arthritis
  • IVERMECTIN for Strongyloidiasis